Liberal glucose targets for critically ill diabetic patients: is it time for large clinical trials with more personalized endpoints?

dc.contributor.authorJacobi, Judith
dc.contributor.departmentSchool of Medicineen_US
dc.date.accessioned2016-12-21T20:26:14Z
dc.date.available2016-12-21T20:26:14Z
dc.date.issued2016-09
dc.eprint.versionPublished versionen_US
dc.identifier.citationJacobi, J. (2016). Liberal glucose targets for critically ill diabetic patients: is it time for large clinical trials with more personalized endpoints? Annals of Translational Medicine, 4(18), 358. https://doi.org/10.21037/atm.2016.08.64en_US
dc.identifier.issn2305-5839 2305-5847en_US
dc.identifier.urihttps://hdl.handle.net/1805/11702
dc.language.isoen_USen_US
dc.publisherATMen_US
dc.relation.isversionof10.21037/atm.2016.08.64en_US
dc.relation.journalAnnals of Translational Medicineen_US
dc.rightsPublisher's Policyen_US
dc.sourcePMCen_US
dc.subjectDiabetesen_US
dc.titleLiberal glucose targets for critically ill diabetic patients: is it time for large clinical trials with more personalized endpoints?en_US
dc.typeArticleen_US
ul.alternative.fulltexthttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066046/en_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
atm-04-18-358.pdf
Size:
96.17 KB
Format:
Adobe Portable Document Format